Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03958383 |
| Title | IT-hu14.18-IL2 With Radiation, Nivolumab and Ipilimumab for Melanoma |
| Recruitment | Suspended |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | University of Wisconsin, Madison |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |